KUROBE PHARMACEUTICALS, INC.

Profile

Company Names

KUROBE PHARMACEUTICALS, INC.

Addresses

400 N ASHLEY DRIVE, SUITE 2150, TAMPA, FL 33602

Phone Numbers

813-579-2550

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$5,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-05-21 
$5,000,000.00 
$6,000,000.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BARRY 
 
BUTLER 
EXECUTIVE OFFICER, DIRECTOR
SIRION HOLDINGS, INC.   |  SIRION HOLDINGS, INC.   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  BETALIQ INC   |  SUBIOMED, INC.
HALEY 
 
BUTLER 
EXECUTIVE OFFICER
KUROBE PHARMACEUTICALS, INC.
YVONNE 
 
GALLIMORE 
EXECUTIVE OFFICER
KUROBE PHARMACEUTICALS, INC.
SEAN 
 
IANCHULEV 
DIRECTOR
CORINTHIAN OPHTHALMIC, INC.   |  KUROBE PHARMACEUTICALS, INC.
EIJI 
 
KATAYAMA 
DIRECTOR
KUROBE PHARMACEUTICALS, INC.
CURT 
 
LABELLE 
DIRECTOR
SAFEOP SURGICAL, INC.   |  EXAGEN DIAGNOSTICS INC   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  INPRESS TECHNOLOGIES, INC.   |  REVELATION BIOSCIENCES, INC   |  OPHIREX, INC.   |  CXL OPHTHALMICS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  RESOLUTE RESOURCES LTD./CAN   |  NOVOCUFF, INC.
NAOHITO 
 
TAKAHASHI 
DIRECTOR
KUROBE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-06-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#